We focus on growing our portfolio, developing and improving virotherapy medicines that meet the real needs of patients.
We invest in biomanufacturing. It is a process of specialized technology, scientific advance and competent employees. We are committed to expand our global reach for the benefit of our patients and partners.
ExploreSafety matters. We ensure that both the benefits and risks of a medication are continuously monitored and approved by regulators, health care providers.
Read More
Clinical studies from 1968
Genetically not modified oncolytic virus
Live and non-pathogenic immunomodulator
Effective and harmless cancer treatment
We are all different and so are the biological reactions to medical products. Some are rare and cannot be detected during clinical development or even extensive trials. The worldwide feedback on these adverse reactions is of greatest importance for systematic maintenance of patient and medication safety.
ReportAccess all the training, guidelines, support and professional resources for the application of virotherapy.
Learn More
Counterfeit virotherapy medication is a risk to warn about and protect our patients from.
Read More